Eleven Therapeutics
London, United Kingdom
Eleven Therapeutics is a TechBio company specializing in next-generation RNA therapeutics by integrating combinatorial chemistry, synthetic biology, and artificial intelligence. Their proprietary platforms, TERA™ and DELiveri™, enable the development of extended-release mRNA therapeutics (xRNA) and prophylactic siRNAs, addressing unmet medical needs in metabolic, hematologic, and infectious diseases.
Company Info
- Founded
- 2021
- Website
- www.scionxbio.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Eleven Therapeutics?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.